Comment on: Jones et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study). Diabetes Care 2011;34:828-837.
Alper
A
Sonmez
Abdullah
A
Taslipinar
Serkan
S
Tapan
Muhittin A
MA
Serdar
D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D024821:Metabolic Syndrome / Q000503:physiopathology*; D013739:Testosterone / Q000009:adverse effects* / Q000627:therapeutic use*
D013739:Testosterone